<% ADLIST_MEGA section={"sectionId":"NEWS1","pickFromSponsorship":true,"pickFromHorizontal":true} section={"sectionId":"NEWS2","pickFromSponsorship":true,"pickFromHorizontal":true} section={"sectionId":"NEWS3","pickFromSponsorship":true,"pickFromHorizontal":true} section={"sectionId":"NEWS4","pickFromSponsorship":true,"pickFromHorizontal":true} section={"sectionId":"NEWS5","pickFromSponsorship":true,"pickFromHorizontal":false} section={"sectionId":"FEATUREDCONTENT","pickFromSponsorship":true,"pickFromHorizontal":true} issueId=10BDD3B6-18FF-45B4-90F6-500E73ACD335%>
Study: Transfusion decisions vary widely in surgery | Silicone "trap" could reduce blood volume needed for tests | Microfluidic device extracts cancer cells from blood samples
Advertisement
April 26, 2012
AABB SmartBrief
News for the transfusion medicine and cellular therapy community
SIGN UP ⋅   FORWARD
Top Story
Study: Transfusion decisions vary widely in surgery
Doctors' decisions on when to transfuse can vary widely, and the association between transfusion and patient outcomes is inconsistent, according to a Johns Hopkins University study published in the journal Anesthesiology. Researchers evaluated the records of more than 48,000 patients, almost 3,000 of whom received blood transfusions during surgery, and found notable differences in hemoglobin levels at the time of transfusion. Doctors should be more aware of transfusion guidelines, and more education is needed, researchers said. Read about the AABB clinical practice guideline on red cell transfusion here.
The Sun (Baltimore)/Picture of Health blog (4/25) 
LinkedIn Twitter Facebook Google+ Email
Donor Recruiting & Retention is About to Get Easier
The Pareto principle, aka the 80-20 rule, says that 80% of effects are the result of 20% of causes. In the donor recruiting world, that can be interpreted to mean 80% of donations come from 20% of your donors. You need an aggressive donor loyalty and retention strategy that's always on and always there. Get ready for the future of donor recruiting and retention. Learn more.
Advertisement
<% ADLIST_BEGIN %>
Science & Health
[[ logo ]]
Science & Health
<% ADLIST_END sectionId=NEWS1 ISLOGO %>
<% ADLIST_BEGIN %><% ADLIST_END sectionId=NEWS1 MEDIUM_RECTANGLE %>
Silicone "trap" could reduce blood volume needed for tests
Researchers have developed a device that uses a silicone compound to trap a single droplet of liquid, preventing evaporation or contamination. By preserving blood during transportation, the technique could allow single-droplet blood testing, researchers said. The findings were published in the Proceedings of the Royal Society A.
Science online/ScienceNow blog (4/24) 
LinkedIn Twitter Facebook Google+ Email
Microfluidic device extracts cancer cells from blood samples
Researchers from Harvard University and Children's Hospital Boston have developed a device for extracting circulating tumor cells from blood, and the device has potential applications in collecting stem cells. Tests on mice showed the microfluidic device can catch more than 90% of the cancerous cells and keep them intact for culturing, according to findings published in the journal Lab on a Chip.
CNET/Cutting Edge blog (4/25) 
LinkedIn Twitter Facebook Google+ Email
Autologous cell therapy shows promise in anti-wrinkle trials
Injections of a patient's cultured collagen-producing fibroblast cells improved the appearance of nasolabial fold wrinkles in late-state clinical trials, according to research published in the journal Dermatologic Surgery.
The Dermatologist online (4/20) 
LinkedIn Twitter Facebook Google+ Email
<% ADLIST_BEGIN %> #990000 16px Helvetica bold color:#990000; font-size:16px; font-family:Helvetica; font-weight:bold; text-decoration:none; line-height:20px; display: block; #000000 14px Helvetica normal font-family:Helvetica; font-size:14px; color:#000000; line-height: 20px; <% ADLIST_END sectionId=NEWS1 %>
<% ADLIST_BEGIN %>
Emerging Trends
[[ logo ]]
Emerging Trends
<% ADLIST_END sectionId=NEWS2 ISLOGO %>
<% ADLIST_BEGIN %><% ADLIST_END sectionId=NEWS2 MEDIUM_RECTANGLE %>
Biopharma is developing almost 300 vaccines
There are almost 300 preventive and therapeutic vaccines under development by biotech firms, according to the Pharmaceutical Research and Manufacturers of America. Vaccines in clinical studies or under FDA review include 170 for infectious diseases and 102 for cancer.
PharmaTimes (U.K.) (4/24) 
LinkedIn Twitter Facebook Google+ Email
Ultrasound alone may rule out deep vein thrombosis in pregnancy
A study published online in the British Medical Journal showed a single ultrasound test could rule out deep vein thrombosis during and after pregnancy. Researchers followed 210 women who received a complete compression ultrasonography exam. Only two of 177 women who tested negative developed DVT during the follow-up period.
Medscape (free registration) (4/24) 
LinkedIn Twitter Facebook Google+ Email
 
<% ADLIST_BEGIN %> #990000 16px Helvetica bold color:#990000; font-size:16px; font-family:Helvetica; font-weight:bold; text-decoration:none; line-height:20px; display: block; #000000 14px Helvetica normal font-family:Helvetica; font-size:14px; color:#000000; line-height: 20px; <% ADLIST_END sectionId=NEWS2 %>
<% ADLIST_BEGIN %>
.
[[ fcSectionHeader ]]
[[ subHeader ]]
[[ logo ]]
[[ fcSectionHeader ]]
[[ subHeader ]]
LinkedIn Twitter Facebook Google+ 
LinkedIn Twitter Facebook Google+ 
1430EB90-12D1-4526-ADFE-60AEAC44798E 10BDD3B6-18FF-45B4-90F6-500E73ACD335 #990000 16px Helvetica bold color:#990000; font-size:16px; font-family:Helvetica; font-weight:bold; text-decoration:none; line-height:20px; display: block; #000000 14px Helvetica normal font-family:Helvetica; font-size:14px; color:#000000; line-height: 20px; padding-left:15px; padding-right:15px; 14px
Click here to learn more about Featured Content
<% ADLIST_END sectionId=FEATUREDCONTENT %>
<% ADLIST_BEGIN %>
Industry News & Practice
[[ logo ]]
Industry News & Practice
<% ADLIST_END sectionId=NEWS3 ISLOGO %>
<% ADLIST_BEGIN %><% ADLIST_END sectionId=NEWS3 MEDIUM_RECTANGLE %>
Small health groups remain slow to adopt EHRs, studies show
A pair of studies in the journal Health Affairs indicated that small, rural hospitals and physician practices continue to lag large, urban facilities in implementing EHRs. The researchers recommended the federal government continue to provide incentives and assistance to smaller practices and step up efforts to help slow adopters deploy EHRs.
Modern Healthcare (subscription required) (4/25) 
LinkedIn Twitter Facebook Google+ Email
<% ADLIST_BEGIN %> #990000 16px Helvetica bold color:#990000; font-size:16px; font-family:Helvetica; font-weight:bold; text-decoration:none; line-height:20px; display: block; #000000 14px Helvetica normal font-family:Helvetica; font-size:14px; color:#000000; line-height: 20px; <% ADLIST_END sectionId=NEWS3 %>
<% ADLIST_BEGIN %>
Government & Regulatory
[[ logo ]]
Government & Regulatory
<% ADLIST_END sectionId=NEWS4 ISLOGO %>
<% ADLIST_BEGIN %><% ADLIST_END sectionId=NEWS4 MEDIUM_RECTANGLE %>
FDA user fee reauthorization faces obstacles
Differences between House and Senate versions of bills reauthorizing the FDA Prescription Drug User Fee Act could delay the bill's progress. Differences include terms for exclusivity periods for new antibiotics, the FDA's mission and guidelines for how the agency determines devices' risks.
Politico (4/25) 
LinkedIn Twitter Facebook Google+ Email
<% ADLIST_BEGIN %> #990000 16px Helvetica bold color:#990000; font-size:16px; font-family:Helvetica; font-weight:bold; text-decoration:none; line-height:20px; display: block; #000000 14px Helvetica normal font-family:Helvetica; font-size:14px; color:#000000; line-height: 20px; <% ADLIST_END sectionId=NEWS4 %>
Association News
Transfusion journal highlights use of platelets to reverse antiplatelet drug effects
An article published in the April issue of Transfusion focuses on the transfusion of platelets to reverse antiplatelet drug effects. The article describes the mechanism of action of new antiplatelet agents and assesses treatment approaches to reverse their action with platelet transfusion or other pharmacologic agents. Continuing medical education credits are being offered for reading and successfully completing a test on the article. Read the abstract or visit the CME website.
LinkedIn Twitter Facebook Google+ Email
Learn more about AABB®:
Homepage | Join AABB | Conferences
Marketplace | AABB CareerLink
JOBS
powered by
Country Director - Mozambique
AABB - 
Senior Project Manager
BLOOD SYSTEMS, INC. - 
Transfusion Safety Coordinator
PACIFIC DIAGNOSTIC LABORATORIES, LLC - 
Standards Development Specialist
AABB - 
(CEO), Greater Ozarks Region
AMERICAN RED CROSS - 
Deputy Director, Regulatory Affairs - Cellular Therapy
AABB - 
<% ADLIST_BEGIN %>
SmartQuote
[[ logo ]]
<% ADLIST_END sectionId=NEWS5 ISLOGO %>
<% ADLIST_BEGIN %><% ADLIST_END sectionId=NEWS5 MEDIUM_RECTANGLE %>
  
  
One person with a belief is equal to a force of 99 who have only interests.
John Stuart Mill,
British philosopher and political economist
LinkedIn Twitter Facebook Google+ Email
  
  
<% ADLIST_BEGIN %> #990000 16px Helvetica bold color:#990000; font-size:16px; font-family:Helvetica; font-weight:bold; text-decoration:none; line-height:20px; display: block; #000000 14px Helvetica normal font-family:Helvetica; font-size:14px; color:#000000; line-height: 20px; <% ADLIST_END sectionId=NEWS5 %>
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information